National Bank of Canada’s XBiotech XBIT Stock Holding History

National Bank of Canada’s Portfolio XBIT Stock Details XBIT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$58.8K	Hold	25,000	–	–	﹤0.01%	1932
2025 Q4	$58.8K	Hold	25,000	–	–	﹤0.01%	1933
2025 Q3	$66K	Hold	25,000	–	–	﹤0.01%	1863
2025 Q2	$74K	Hold	25,000	–	–	﹤0.01%	1866
2025 Q1	$80.3K	Hold	25,000	–	–	﹤0.01%	1755
2024 Q4	$98.8K	Sell	25,000 -8,000	-24%	-$54.5K	﹤0.01%	1763
2024 Q3	$255K	Hold	33,000	–	–	﹤0.01%	1335
2024 Q2	$182K	Hold	33,000	–	–	﹤0.01%	1364
2024 Q1	$272K	Buy	33,000 +8,653	+36%	+$49.6K	﹤0.01%	1369
2023 Q4	$103K	Buy	+24,347	New	+$97K	﹤0.01%	1570

Other funds holding XBIT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

National Bank of Canada's XBIT Position: Q1 2026 in Review

National Bank of Canada held its XBiotech (XBIT) position steady in Q1 2026 at 25,000 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

National Bank of Canada first reported a position in XBIT in Q4 2023 and has held it in 10 quarters since. The position peaked at $272K in Q1 2024. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

National Bank of Canada held 25,000 shares of XBiotech worth $58.8K as of Q1 2026.
National Bank of Canada left its XBiotech share count unchanged in Q1 2026.
XBiotech made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #1932 holding.
National Bank of Canada first reported a position in XBiotech in Q4 2023 and has held it in 10 quarters since.
National Bank of Canada's XBiotech position peaked at $272K in Q1 2024.
37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.